Todd Alfred Carter is Chief Scientific Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 87,627 shares of VYGR, which is worth approximately $475,814. The most recent transaction as insider was on Feb 21, 2024, when has been sold 3,365 shares (Common Stock) at a price of $7.47 per share, resulting in proceeds of $25,136. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.6K
0% 3M change
61.2% 12M change
Total Value Held $475,814

Todd Alfred Carter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2024
SELL
Open market or private sale
$25,136 $7.47 p/Share
3,365 Reduced 3.7%
87,627 Common Stock
Feb 20 2024
SELL
Open market or private sale
$4,623 $7.68 p/Share
602 Reduced 0.66%
90,992 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
38,500 Added 29.59%
91,594 Common Stock
Jan 17 2024
SELL
Open market or private sale
$9,089 $7.18 p/Share
1,266 Reduced 2.33%
53,094 Common Stock
Sep 15 2023
SELL
Open market or private sale
$85,680 $8.16 p/Share
10,500 Reduced 16.19%
54,360 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
$14,250 $2.85 p/Share
5,000 Added 7.16%
64,860 Common Stock
Jul 06 2023
SELL
Open market or private sale
$59,400 $10.8 p/Share
5,500 Reduced 8.41%
59,860 Common Stock
Jun 30 2023
SELL
Open market or private sale
$57,050 $11.41 p/Share
5,000 Reduced 7.11%
65,360 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
$14,250 $2.85 p/Share
5,000 Added 6.63%
70,360 Common Stock
Mar 20 2023
SELL
Open market or private sale
$17,017 $7.76 p/Share
2,193 Reduced 3.25%
65,360 Common Stock
Feb 17 2023
SELL
Open market or private sale
$5,498 $7.45 p/Share
738 Reduced 1.08%
67,553 Common Stock
Feb 17 2023
BUY
Grant, award, or other acquisition
-
34,000 Added 33.24%
68,291 Common Stock
Feb 13 2023
SELL
Open market or private sale
$6,112 $7.67 p/Share
797 Reduced 2.27%
34,291 Common Stock
Jan 17 2023
SELL
Open market or private sale
$11,015 $9.96 p/Share
1,106 Reduced 3.06%
35,088 Common Stock
Jan 06 2023
SELL
Open market or private sale
$2,487 $6.41 p/Share
388 Reduced 1.06%
36,194 Common Stock
Dec 31 2022
BUY
Grant, award, or other acquisition
$2,005 $5.17 p/Share
388 Added 1.05%
36,582 Common Stock
TAC

Todd Alfred Carter

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR